CC
PFE icon

Carlson Capital’s Pfizer PFE Stock Holding History

Carlson Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-40,000
Closed -$1.12M – 65
2024
Q2 		$1.12M Buy
40,000
+10,000
+33% +$275K 0.17% 83
2024
Q1 		$833K Buy
+30,000
New +$832K 0.07% 102
2017
Q3 		– Sell
-449,226
Closed -$14.3M – 255
2017
Q2 		$14.3M Sell
449,226
-1,639,321
-78% -$51.7M 0.2% 155
2017
Q1 		$67.8M Buy
2,088,547
+484,207
+30% +$15.3M 0.86% 32
2016
Q4 		$49.4M Buy
+1,604,340
New +$49M 0.59% 50
2016
Q3 		– Sell
-320,908
Closed -$10.7M – 305
2016
Q2 		$10.7M Sell
320,908
-185,056
-37% -$5.91M 0.13% 193
2016
Q1 		$14.2M Buy
+505,964
New +$14.5M 0.17% 167

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Carlson Capital's PFE Position: Q3 2024 in Review

Carlson Capital sold out of Pfizer (PFE) in Q3 2024, closing a stake of 40,000 shares — an estimated $1.12M sold.

Carlson Capital first reported a position in PFE in Q1 2016 and held it in 7 quarters. The position peaked at $67.8M in Q1 2017. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Carlson Capital reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • Carlson Capital sold 40,000 Pfizer shares in Q3 2024, an estimated $1.12M.
  • Carlson Capital first reported a position in Pfizer in Q1 2016 and held it in 7 quarters.
  • Carlson Capital's Pfizer position peaked at $67.8M in Q1 2017.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Carlson Capital's 13F filing for Q3 2024, filed 14 Nov 2024.